FDA Inspection 1251210 — Beiersdorf AG
The FDA completed an inspection of Beiersdorf AG on Dec 9, 2021 in Hamburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 9, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hamburg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)